The NHC-coordinated trisilacyclopropylidene (A) is shown to behave as the basic component of an FLP used in combination with the Lewis acid B(C6F4H)3 (i.e. B(2,3,5,6-C6F4H)3). This FLP cleaves dihydrogen highly selectively at room temperature giving rise to the ionic compound [(NHC)SiH(Mes2SiSiMes2)][HB(C6F4H)3] 1 in 90% isolated yield. Further reaction of the FLP with Ph2NH and acetone yielded compounds [(NHC)SiH(Mes2SiSiMes2)][Ph2NB(C6F4H)3] 2 and [(NHC)SiH(Mes2SiSiMes2)][MeC(CH2)OB(C6F4H)3] 3 in 75% and 80% yield, respectively. Reaction of the FLP with N2O results in the oxidation of the silylene center affording [((NHC)SiOB(C6F4H)3)(Mes2SiSiMes2)] 4 in 53% yield. These products are spectroscopically characterized and an X-ray structure of 4 is reported.New coarse-grained models are introduced for a non-ionic chromonic molecule, TP6EO2M, in aqueous solution. The multiscale coarse-graining (MS-CG) approach is used, in the form of hybrid force matching (HFM), to produce a bottom-up CG model that demonstrates self-assembly in water and the formation of a chromonic stack. However, the high strength of binding in stacks is found to limit the transferability of the HFM model at higher concentrations. The MARTINI 3 framework is also tested. Here, a top-down CG model is produced which shows self-assembly in solution in good agreement with atomistic studies and transfers well to higher concentrations, allowing the full phase diagram of TP6EO2M to be studied. At high concentration, both self-assembly of molecules into chromonic stacks and self-organisation of stacks into mesophases occurs, with the formation of nematic (N) and hexagonal (M) chromonic phases. This CG-framework is suggested as a suitable way of studying a range of chromonic-type drug and dye molecules that exhibit complex self-assembly and solubility behaviour in solution.Separation of cancerous from normal cells is of broad importance in a large number of cancer diagnosis and treatment methods. One of the most important factors to designate and specify different cells is to study their dielectric and electric cell membrane characteristics. In this research, a label-free cytological slide chip (CSC) is designed and fabricated based on AC electric field stimulation of breast cell lines and blood cells at low frequencies (1 kHz-200 kHz). The AC-CSC traps cells based on their dielectric polarization functions which is distinct between different phenotypes of breast cells and blood cells. We learned that by using AC electric fields, each breast cell line shows a capturing response to a specific range of frequencies. The progression in cancer phenotypes decreases the cell's polarizability. Hence, characteristic frequency responses were achieved for these cells. In this study, thermal potential and electrolysis which were the main bottle neck problems in DC applied fields were completely solved. The AC-CSC could be used in CTC separation from leukocytes, a test performed based on a compound with 1% cancer cells in white blood cells (1% MDA-MB-231  99% WBC) which results in 90% capturing efficiency of cancer cells. Frequency dependent capturing brings so much hope that smart slides will be useful at the clinical stage in the near future.Triplet-triplet annihilation based molecular photon upconversion (TTA-UC) is an exciting research area for a broad range of photonic applications due to its tunable spectral range and possible operation at non-coherent solar irradiance. Most of the TTA-UC studies are limited to Visible to Visible (Vis to Vis) energy upconversion. However, for several practical photonic applications, efficient near infrared (NIR) to Vis upconversion is preferred. Examples include, (i) photovoltaics where TTA-UC could lead to utilization of a larger part of the solar spectrum and (ii) in NIR stimulated biological applications where the deep penetration and non-invasive nature of NIR light coupled to TTA-UC offers new opportunities. Although, NIR to Vis TTA-UC is known since 2007, the recent five years have witnessed quite a progress in terms of the development of new chromophores, hybrid systems and fabrication techniques to increase the UC quantum yield at low excitation intensity. With this tutorial review we are reviewing recent progress, identifying existing challenges and discus possible future directions and opportunities.Alzheimer's disease (AD) is the most common neurodegenerative disorder that leads to cognitive and behavioral impairment. Unfortunately, both effective diagnosis and treatment for AD remain elusive, probably owing to the complicated and uncertain etiology of the disease. To date, a number of hypotheses have been proposed that may explain AD pathogenesis, including the amyloid cascade hypothesis, the tau hypothesis, the cholinergic hypothesis, the metal ion hypothesis, the oxidative stress hypothesis and so on. Thus, the development of multifunctional compounds capable of concurrently targeting multiple pathogenic factors of AD has been suggested as an effective solution to combat this disease. https://www.selleckchem.com/products/i-bet151-gsk1210151a.html Nano-enabled delivery systems (NDS) have promising potential to achieve multifunctional diagnostics/therapeutics against various targets of AD simultaneously due to the unique advantages of nanocarriers, such as easy multifunctionalization on surfaces, high surface-to-volume ratio with large payloads, and potential ability to cross the blood-brain barrier (BBB), making them capable of overcoming the limitations of traditional drug candidates. This review focuses on the recent developments of multifunctional NDS in AD management, including multitherapeutics, multimodal imaging-guided diagnostics, and theranostics. The multifunctionalization strategies, working mechanisms, and in vivo activities of the representative examples are highlighted. Finally, the opportunities and challenges of multifunctional NDS for future research are also discussed.Taiwanese women frequently receive Shenghua decoction treatment for uterus involution. However, prolonged Shenghua decoction treatment can be detrimental. Herein, we report the case of a woman with disastrous postpartum hemorrhage after prolonged Shenghua decoction treatment. A 36-year-old woman underwent scheduled cesarean delivery due to cephalopelvic disproportion. On the 8th postpartum day, she started taking Shenghua decoction twice per day. Massive vaginal bleeding was noted after 3 days of Shenghua decoction treatment. Emergency hysterectomy was performed due to severe hypotension and refractory postpartum hemorrhage. Despite being rare, disastrous delayed postpartum hemorrhage could occur after 3 days of Shenghua decoction treatment. Further research might be needed to clarify the relationship between prolonged Shenghua decoction treatment and delayed postpartum hemorrhage.